Austin G E, Zhao W G, Zhang W, Austin E D, Findley H W, Murtagh J J
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Leukemia. 1995 May;9(5):848-57.
Myeloperoxidase (MPO) is a microbicidal protein present in the primary granules of myeloid cells. Transcription of the MPO gene is turned on only during the late myeloblast and promyelocyte stages of myeloid maturation. Identification of cis-regulatory elements and transcription factors which regulate the MPO gene should, therefore, shed light on myeloid maturation. We report transfection and in vitro transcription experiments which demonstrate promoter activity in the proximal 5'-flanking region of the human MPO gene. Using a chloramphenicol acetyl transferase (CAT) reporter vector system, and segments of the 5'-flanking MPO DNA, we constructed a series of MPO promoter-CAT expression vectors. By electroporation and lipofectin-mediated transient transfection assays, as well as by in vitro transcription studies, a 594-bp MPO DNA sequence (bp -583 to +11) showed promoter activity in a variety of MPO-expressing and non-MPO-expressing cell lines. Compared with the SV40 early promoter, the MPO promoter had greater relative activity in MPO-expressing than in non-MPO-expressing cell lines, suggesting slight tissue specificity. However, a CAT reporter plasmid containing 1099-bp of 5'-flanking MPO DNA showed greater specificity for MPO expressing cell lines. Analysis of a group of promoter deletion mutants showed that the minimal promoter was contained in a DNA fragment extending from bp-128 to +11. The remainder of the promoter region contained several segments which appeared to enhance the activity of the minimal promoter. One such enhancer sequence was homologous to an enhancer previously described in the human elastase promoter. Activity of the 594-bp MPO promoter in HL-60 was reduced by only approximately 30% following treatment of the cells with chemical inducers of maturation, but the 1099-bp MPO promoter showed 60% reduction in activity after DMSO treatment. A previously described enhancer region in intron 9 of the MPO gene had little or no effect on activity of the 594-bp MPO promoter. The availability of the MPO promoter will facilitate determination of other factors involved in the regulation of this myeloid-specific gene.
髓过氧化物酶(MPO)是一种存在于髓样细胞初级颗粒中的杀菌蛋白。MPO基因的转录仅在髓样成熟的晚幼粒细胞和早幼粒细胞阶段开启。因此,鉴定调控MPO基因的顺式调控元件和转录因子应有助于阐明髓样成熟过程。我们报告了转染和体外转录实验,这些实验证明了人MPO基因近端5'侧翼区域的启动子活性。使用氯霉素乙酰转移酶(CAT)报告载体系统和5'侧翼MPO DNA片段,我们构建了一系列MPO启动子-CAT表达载体。通过电穿孔和脂质体介导的瞬时转染分析以及体外转录研究,一个594 bp的MPO DNA序列(bp -583至+11)在多种表达MPO和不表达MPO的细胞系中显示出启动子活性。与SV40早期启动子相比,MPO启动子在表达MPO的细胞系中比在不表达MPO的细胞系中具有更高的相对活性,表明有轻微的组织特异性。然而,一个包含1099 bp 5'侧翼MPO DNA的CAT报告质粒对表达MPO的细胞系具有更高的特异性。对一组启动子缺失突变体的分析表明,最小启动子包含在从bp-128至+11延伸的DNA片段中。启动子区域的其余部分包含几个似乎增强最小启动子活性的片段。其中一个这样的增强子序列与先前在人弹性蛋白酶启动子中描述的增强子同源。在用化学成熟诱导剂处理细胞后,HL-60中594 bp MPO启动子的活性仅降低了约30%,但1099 bp MPO启动子在二甲基亚砜处理后活性降低了60%。先前在MPO基因内含子9中描述的一个增强子区域对594 bp MPO启动子的活性几乎没有影响。MPO启动子的可用性将有助于确定参与调控这个髓样特异性基因的其他因素。